NCT00563836
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
- Locations
-
- Innsbruck, Austria
- Klinikum Charité Berlin, Germany
Clinical trial condition
Epithelial Ovarian Cancer
Explore clinical trials studying Epithelial Ovarian Cancer. Study availability and eligibility vary by location and protocol.
142 public trials
36 recruiting studies
Epithelial Ovarian Cancer trial results
NCT00281515
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
- Locations
-
- Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik für Frauenheilkunde Berlin, Germany
- Klinikum Bremen Mitte, Frauenklinik Bremen, Germany
- Carl-Gustav-Carus der TU Dresden, Universitäts-Frauenklinik Dresden, Germany
- Ev. Krankenhaus, Frauenklinik Düsseldorf, Germany
NCT00407563
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
- Locations
-
- Little Rock Hematology Oncology Little Rock, Arkansas, United States
- Wilshire Oncology Medical Group, Inc. La Verne, California, United States
- Northeast Georgia Cancer Care, LLC Athens, Georgia, United States
- Southeastern Gynecologic Oncology, LLC Atlanta, Georgia, United States
NCT00561795
- Conditions
- Adnexal Diseases, Cancer, Carcinoma, +25 more
- Locations
-
- GSK Investigational Site Lyon, France
- GSK Investigational Site Strasbourg, France
- GSK Investigational Site Marburg, Hesse, Germany
- GSK Investigational Site Wiesbaden, Hesse, Germany
Completed
Women Surviving Ovarian Cancer
NCT00596349
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +19 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT00490711
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bratislava, Slovakia
Active, Not Recruiting
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
NCT03872947
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +58 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- AOA-HOPE Tucson, Arizona, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- HOAG Memorial Hospital Presbyterian Newport, California, United States
Active, Not Recruiting
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors
NCT02644369
- Conditions
- Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +33 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Active, Not Recruiting
T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors
NCT05200559
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
NCT04152499
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
- Locations
-
- Los Angeles Hematology Oncology Medical Group Glendale, California, United States
- University of California Los Angeles Los Angeles, California, United States
- Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
- START MidWest Grand Rapids, Michigan, United States